← Open Payments lookup

TIZITA TESSEMA: Open Payments

NPI 1528612397 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$495 in 23 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $192 · 2025 $495

Food & beverage: $495
CompanyPaymentsAmount
Lilly USA, LLC4$102
PFIZER INC.4$78
Amgen Inc.4$75
AstraZeneca Pharmaceuticals LP3$73
Novo Nordisk Inc2$44
Merck Sharp & Dohme LLC2$43
Boehringer Ingelheim Pharmaceuticals, Inc.2$37
ABBVIE INC.1$24
GlaxoSmithKline, LLC.1$19

Products named: MOUNJARO, ELIQUIS, AIRSUPRA, OTEZLA, GARDASIL 9, JARDIANCE, REPATHA, QULIPTA.

Industry payments across DC — which companies pay providers there.